ArticleFrontiers in oncology2023

Efficacy and safety of third-line or later-line targeted treatment for patients with metastatic colorectal cancer: a meta-analysis.

Wen-Hui Xue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.